Period and velocity of PeCoWaCo are stable across a broad range of cell sizes. by Özge Özgüç (12290245)

Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a... by Dario Giugliano (10218354)

“…At 6 months, patients experienced similar reduction in HbA1c level (-0.6 ± 0.8, -0.6 ± 0.8, -0.7 ± 0.9%, mean ± SD, respectively, noninferiority P < 0.001 vs BBI) and the proportion of patients with HbA1c ≤7.5% was also similar (34%, 28% and 27%, respectively, P = 0.489). …”

Mean absolute shapley additive explanation (SHAP) values of most important predictors for multinomial-encoding all-predictor-based model (APM_MN). by Shubhayu Bhattacharyay (11242977)

Simulation results from mean field coupled oscillator model. by Ryan Tasseff (253998)

Fig 1 - by Ingmar Lundquist (46422)

Histograms of <i>I</i>_s and Δ<i>D.</i> by Hong Zhang (25820)

Testing equipment and typical specimen failure modes: by Hong Zhang (25820)

Effect of Cytosolic pH on Inward Currents Reveals Structural Characteristics of the Proton Transport Cycle in the Influenza A Protein M2 in Cell-Free Membrane Patches of <i>Xenopus... by Mattia L. DiFrancesco (364045)

“…<div><p>Transport activity through the mutant D44A of the M2 proton channel from influenza virus A was measured in excised inside-out macro-patches of <i>Xenopus laevis</i> oocytes at cytosolic pH values of 5.5, 7.5 and 8.2. …”

Fig 1 - by Sheona Isobel Shankland (19976311)

Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension by Tetsuo Asaki (1366140)

“…Compound <b>26a</b> was developed for the treatment of pulmonary arterial hypertension and shown to reduce the risk of the composite morbidity/mortality end point in a phase 3 event-driven clinical trial.…”

Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension by Tetsuo Asaki (1366140)

“…Compound <b>26a</b> was developed for the treatment of pulmonary arterial hypertension and shown to reduce the risk of the composite morbidity/mortality end point in a phase 3 event-driven clinical trial.…”

Structural components of transmission networks across the lockdown. by Matteo Serafino (11599593)

Phenotypes and Mg contents of banana (<i>Musa acuminata</i>) leaves under long-term MD. by Baolin Kan (12936933)

Mean ± SEM FPKM values measured for differentially expressed genes. by Sarah W. Keenan (765990)

“…The mean FPKM values, P-values, sequence length, and exon density for each of these genes can be found in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0131669#pone.0131669.s005" target="_blank">S1</a>–<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0131669#pone.0131669.s007" target="_blank">S3</a> Tables.…”

Effects of the adenosine A_2A antagonist MSX-3 on PROG/chow performance. by Patrick A. Randall (302096)

“…<p>On measures of lever pressing, mean (±SEM) total lever presses (A) and maximum ratio achieved (B) were both significantly increased at doses of 1.0 and 2.0 mg/kg while active lever time (measured in seconds, C) was only increased at a dose of 2.0 mg/kg. …”

<i>Kif15</i> deficient mice exhibit both depressive and manic behaviors in adulthood. by Xiaomei He (795333)

Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and meta-analysis by Ruolin Wang (1556374)

“…Stimulation days (mean difference (MD) [95% confidence interval (CI)] = -0.8 [-1.36, -0.23], P = 0.006), gonadotrophin (Gn) dosage (MD [95% CI] = -3.52 [-5.56, -1.48], P = 0.0007), estradiol (E2) level on the day of human chorionic gonadotrophin (HCG) administration (MD [95% CI] = -365.49 [-532.93, -198.05], P<0.0001), the number of oocytes retrieved (MD [95% CI] = -1.41 [-1.84, -0.99], P<0.00001), the embryos obtained (MD [95% CI] = -0.99 [-1.38, -0.59], P<0.00001), incidence of ovarian hyperstimulation syndrome (OHSS) (OR [95% CI] = 0.69 [0.57, 0.83], P<0.0001) were statistically significantly lower in GnRH-ant protocol than GnRH-a long protocol. …”

Immunohistological analysis of the post-mortem gingival tissue. by Salomé Mascarell (20234689)

Dynamic trajectory and parameter sensitivity ranking in the SSA simulation. by Xianli Chen (5410013)

“…T1 indicates the time point at which the system starts to transform to a high state, T2 represents the time at which the first mean value of high steady state is reached, and FPT is a value between T1 and T2, and indicating the time when Bax₄ ^MOM number first reaches 80% of mean value of high state. …”

The pilot-scale tests bench. by Xiaobo Li (118828)